Navigation Links
Novartis begins shipment of seasonal influenza vaccines to US market
Date:8/21/2013

lifornia/7/2009-like virus)
  • A/Texas/50/2012, NYMC X-223A (H3N2) (an A/Victoria/361/2011-like virus)
  • B/Massachusetts/2/2012
  • For Flucelvax, these include7:

    • A/Brisbane/10/2010 (H1N1) (an A/California/7/2009-like virus)
    • A/Texas/50/2012, NYMC X-223A (H3N2) (an A/Victoria/361/2011-like virus)
    • B/Massachusetts/2/2012

    Fluvirin
    Fluvirin (Influenza Virus Vaccine) is an inactivated influenza virus vaccine indicated for active immunization of persons 4 years of age and older against influenza disease caused by influenza virus subtypes A and type B contained in the vaccine6.

    Fluvirin is contraindicated for individuals with a history of severe allergic reactions (e.g., anaphylaxis) to egg proteins, or any component of Fluvirin, or life-threatening reactions to previous influenza vaccinations6.

    In clinical trials, the most common adverse events in adults were headache, fatigue, injection site reactions (pain, mass, redness, and induration), and malaise. These adverse events were generally mild/moderate and transient8.

    Flucelvax
    Flucelvax (Influenza Virus Vaccine) is an inactivated vaccine indicated for active immunization for the prevention of influenza disease caused by influenza virus subtypes A and type B contained in the vaccine.  Flucelvax is approved for use in persons 18 years of age and older7.

    Flucelvax is contraindicated for individuals with a history of severe allergic reaction (e.g. anaphylaxis) to any component of the vaccine7.

    The safety and efficacy profile of Flucelvax is comparable to other seasonal
    '/>"/>

    SOURCE Novartis
    Copyright©2012 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8

    Related medicine technology :

    1. Novartiss Serelaxin Has the Potential to Fulfill the Most Pertinent Unmet Needs in Acute Heart Failure by Reducing the Rate of Patient Mortality and the Rate of Worsening Renal Function
    2. Novartis Breakthrough Therapy LDK378 shows a marked clinical response in patients with ALK+ non-small cell lung cancer
    3. Novartis Pharmaceuticals Corporation disputes allegations in two US Government lawsuits and looks forward to a fair discussion of the facts
    4. Novartis signs on to support Malaria No Mores Power of One campaign to stride towards a future without malaria
    5. Novartis Reports Omalizumab Significantly Improved Chronic Idiopathic Urticaria Symptoms in Patients Who Failed Standard Therapy
    6. Novartis Pharma Logistics, Inc. voluntarily recalling in Jamaica select lots of certain over-the-counter products due to bottle closure defect
    7. Novartis Pharma Logistics, Inc. voluntarily recalling in Trinidad & Tobago select lots of certain over-the-counter products due to bottle closure defect
    8. Novartis Pharma Logistics, Inc. voluntarily recalling in Curacao select lots of certain over-the-counter products due to bottle closure defect
    9. Novartis Pharma Logistics, Inc. voluntarily recalling in Aruba select lots of certain over-the-counter products due to bottle closure defect
    10. Novartis Pharma Logistics, Inc. voluntarily recalling in Barbados select lots of certain over-the-counter products due to bottle closure defect
    11. Continued Uptake of Novartis/Incytes Jakafi Will Be the Greatest Driver of Growth in the Myelofibrosis Therapy Market
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:2/27/2015)... MISSISSAUGA, ON , Feb. 27, 2015 /CNW/ - Covalon ... advanced medical technologies company, today announced financial results for ... For the three months ended December 31, 2014, ... for the quarter was $229,820 or $0.02 per share.  ... Pedlar , said "I am very pleased with the ...
    (Date:2/27/2015)...  Bionik Laboratories Corp. (OTC:DWTPD), a Delaware ... acquired Bionik Laboratories, Inc., a Toronto ... qualified accredited investors of units consisting of its common ... $6.2 million. Shares of the Company,s common stock will ... the symbol "DWTPD" until FINRA,s approval of the ticker ...
    (Date:2/26/2015)... DIEGO , Feb. 26, 2015  Tandem Diabetes ... device company and manufacturer of the t:slim® and t:flex™ ... public offering of 5,250,000 shares of its common stock ... share.  The net proceeds to Tandem from this offering ... discounts and commissions and other estimated offering expenses payable ...
    Breaking Medicine Technology:Covalon Announces First Quarter Financial Results 2Covalon Announces First Quarter Financial Results 3Bionik Laboratories Raises $6.2 Million 2Bionik Laboratories Raises $6.2 Million 3Tandem Diabetes Care Announces Pricing of Underwritten Public Offering of Common Stock 2Tandem Diabetes Care Announces Pricing of Underwritten Public Offering of Common Stock 3
    ... NEW YORK, Feb. 23, 2011 Reportlinker.com announces that ... catalogue: Global Pain Management Industry ... This report analyzes the worldwide markets for Pain Management ... Management Pharmaceuticals, Pain Management Devices, and Pain Management Services. ...
    ... 23, 2011 /PRNewswire-Asia/ -- Global Sources (Nasdaq: ... AsiaWorld-Expo Management (AWE) to host China Sourcing Fairs ... through 2014, in addition to the renewed contracts announced ... approximately US$16.7 million. (Logo: http://photos.prnewswire.com/prnh/20030303/LNM011LOGO-b) ...
    Cached Medicine Technology:Reportlinker Adds Global Pain Management Industry 2Global Sources extends its contract with AsiaWorld-Expo to host China Sourcing Fairs in Hong Kong through 2014 2Global Sources extends its contract with AsiaWorld-Expo to host China Sourcing Fairs in Hong Kong through 2014 3
    (Date:2/28/2015)... March 01, 2015 Heart diseases are ... 10 percent of urban adult population and 5 percent ... heart diseases and 20-30 percent of them require specialized ... ailments and coronary vascular diseases (CVD). , A division ... new market research report titled “Indian Coronary Stent Market ...
    (Date:2/28/2015)... 28, 2015 The Classic Denture ... a new special. Throughout all of March patients ... , This service can help overall mouth ... pain. Patients may notice certain symptoms that suggest the ... These symptoms include: , 1.    Pain, clicking, and popping in ...
    (Date:2/28/2015)... 28, 2015 A study out of ... gene therapy procedure for the treatment of a hereditary ... Authored by Dr. Robert MacLaren, professor of ... the Lancet Medical Journal on January 16, 2014 , ... rare genetic disorder that mostly affects men and leads ...
    (Date:2/28/2015)... Beach, CA (PRWEB) February 28, 2015 ... needs of Central Coast area residents, recently announced a ... System. It’s a treatment option for new and ... kick off 2015 with a bright, white smile, Dr. ... discounted price of $299, marked down from the regular ...
    (Date:2/28/2015)... 28, 2015 On Thursday, February 26th, Forbes ... Easy For Scammers To Steal Your Data , which stresses ... hands on a DIY phishing kit, or any kind of ... on another important point about how everyone’s cyber security is ... implemented, “like compromising legitimate content management systems or blogs in ...
    Breaking Medicine News(10 mins):Health News:India Coronary Stent Market 2019 Forecasts Analysis in New Research Report Available at MarketReportsOnline.com 2Health News:India Coronary Stent Market 2019 Forecasts Analysis in New Research Report Available at MarketReportsOnline.com 3Health News:Classic Denture Center in Portland Oregon is Offering March Discount 2Health News:New Gene Therapy Procedure Could Hold Key to Preventing Blindness for Certain Patients 2Health News:Pismo Beach Dentist Announces Special for Zoom! Teeth Whitening 2Health News:DIY Phishing and Malware Kits Make it Easy to Compromise Businesses in More Ways than One 2Health News:DIY Phishing and Malware Kits Make it Easy to Compromise Businesses in More Ways than One 3Health News:DIY Phishing and Malware Kits Make it Easy to Compromise Businesses in More Ways than One 4
    ... and more complications later, studies find , , MONDAY, Oct. ... arthritis face twice the risk of a heart attack, ... to have more heart-related complications, new research says. ... which causes the lower chambers of the heart to ...
    ... written and verbal instructions on the proper way to ... to suffer the serious gastrointestinal and brain bleeding problems ... to new research from the University of Pennsylvania School ... Journal of General Internal Medicine , also shows ...
    ... Mo. The blood circulates through the body ... beginning to understand. Now, University of Missouri researcher ... and Blood Institute,s prestigious Method to Extend Research ... defining the signaling processes that control blood flow ...
    ... SpectraCell Laboratories, Inc.,announced that it has doubled ... a 20,000 sq. ft. building that was ... expansion added a second freestanding 20,000 sq.,ft. ... $3.5 million facility houses,SpectraCell,s state-of-the-art clinical laboratory ...
    ... offer ,Stem Cells 102, to present facts to ... issues surrounding the,safety and benefits of stem cell ... University of,Michigan experts are providing educational information to ... federal and state,oversight that apply to all human ...
    ... 27 The HealthCentral,Network, Inc. (http://www.HealthCentral.com ) ... business development for HealthCentral, has been,named President and ... a proven track record of growing young businesses, ... be responsible for,audience growth, user engagement, and revenue, ...
    Cached Medicine News:Health News:Rheumatoid Arthritis a Threat to the Heart 2Health News:Rheumatoid Arthritis a Threat to the Heart 3Health News:Rheumatoid Arthritis a Threat to the Heart 4Health News:Better instructions reduce complications among patients using common blood thinner 2Health News:Better instructions reduce complications among patients using common blood thinner 3Health News:Researcher to provide new insight for treating vascular disease 2Health News:SpectraCell Laboratories Expands Operations in New Facility 2Health News:The Truth About Stem Cell Science 2Health News:The Truth About Stem Cell Science 3Health News:The Truth About Stem Cell Science 4Health News:The HealthCentral Network Names Jeremy Shane President and Chief Operating Officer 2Health News:The HealthCentral Network Names Jeremy Shane President and Chief Operating Officer 3
    1.0 mm diameter head, 0.75 mm deep bite....
    Optec vision tester....
    ... standardized glare testing. It can be used with ... evaluation of glare disability. For cataract documentation, the ... two on-coming halogen car headlights as seen at ... be adjusted to simulate other glare conditions, as ...
    Designed to determine the precise length of limbal incisions and proper alignment of closing sutures. Curved marking blade with 2 mm lines spaced 1 mm apart-measures up to 10 mm. Round knurled handle...
    Medicine Products: